🔗 Share this article

An underground market for unlicensed slimming drugs is propelled by social media fitness personalities and vendors on communication apps, based on recent findings.

Experimental Drug Gaining Popularity Online

The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its supposed weight-reducing properties. Viewers are urged to contact these accounts privately for supplier links, while also obtaining discount codes.

Active Commerce on Social Networks

Additionally, a flourishing trade exists on Telegram, where groups with thousands of participants share “before and after” images, injection guides and assertions of next-day British shipping. Sellers promote the drug there before redirecting customers to WhatsApp for purchases.

Understanding The Experimental Drug

This medication is an investigational injection developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could help patients reduce up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being promoted online as the next Ozempic.

Healthcare Professionals Voice Concerns

Nevertheless, doctors and chemists have warned that the sale of what is still an unapproved drug in the United Kingdom is a cause for concern and could result in users injecting substances of unknown origin.

Some professionals said the demand for retatrutide could be linked to the rising cost of approved slimming products such as Mounjaro.

Legal Position and Enforcement

Marketing the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unapproved medication that must not be marketed or distributed for human use under the Human Medicines Regulations 2012.

Several influencers try to circumvent the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but promotion and supply can still breach pharmaceutical, marketing, and customer laws, risking fines, prosecution or imprisonment.

Platform Reaction and Content Elimination

Based on the social media company, the platform has removed violative material and banned associated hashtags and query recommendations. The organization said it was committed to keeping the service safe and allocating resources in enhancing enforcement strategies.

Digital Trading Operations

Research also found groups with up to nine thousand members selling retatrutide using Telegram's integrated search feature, which operates like a online catalog. Entering “retatrutide” instantly displays channels with numerous of users, populated with images of weight loss, glowing testimonials and step-by-step guides for preparing or injecting at home.

After moments of entering one group, a seller posted contact information, where most transactions take place. The vendor sent an guidebook and promised shipping within two days. When asked whether the substance was genuine, one vendor said: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. Not one inquired about body mass, health issues or previous experience.

Product Details and Costs

Within these communities, messages display black plastic parcels with postal service stickers, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at home with sterile water, or ready-to-use pens typically priced at £160 for 20mg. When asked how much time a pen should last, sellers give conflicting responses ranging from a few weeks to “depends on your body”.

Service Oversight and Safety Actions

A spokesperson for Telegram stated it actively moderated dangerous material on its service including material that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are injecting materials they can’t verify. Even if the research behind retatrutide is sound, these digital products may not contain what they claim,” stated a pharmacy expert, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in demand to current cost increases for approved slimming drugs such as Mounjaro. “With prices rising, patients are turning to social media. But fake treatments are highly risky. You cannot know what’s inside or whether the conditions they were made in was clean,” she explained.

Her staff has previously encountered patients harmed by self-injection from unconfirmed sources. “We recognize the frustration, but purchasing from messaging apps or communication platforms is taking chances with your health,” said Wyllie. “These materials could be impure or improperly measured.”

Producer Position

A representative from Eli Lilly said retatrutide was in phase 3 clinical trials and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this point no one can market [it] for human use,” they said, adding that any product “misleadingly claiming itself as a Lilly investigational product not yet authorized … may subject patients to possibly serious health risks”.